QA: SEELOS THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2023_SEELOS_THERAPEUTICS_INC.pdf

Logs

Graph

Absolute values for 0001017491, SEELOS THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 22,674,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 72,000
4 LiabilitiesCurrent 25,158,000
5 LiabilitiesNoncurrent 15,000
6 remainder_Liabilities 8,184,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,296,000
9 ResearchAndDevelopmentExpense 58,620,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -2,618,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,746,000
1 Liabilities 33,357,000
2 Expenses 70,916,000
3 Revenues 0
4 StockholdersEquity -10,611,000
5 NetIncome -73,534,000
6 ComprehensiveNetIncome -73,534,000
7 BaseVar 64,818,500
8 EconomicCapitalRatio -3.27

Edgar->Model Mapping

Feature Distribution

Change over Time